News
Home  >  News > resentation of the UB Chair on Respiratory Health with support from AstraZeneca,...

resentation of the UB Chair on Respiratory Health with support from AstraZeneca, Chiesi and GSK

 

 

17/11/2020

Recerca

This Wednesday, November 18, the UB Chair on Respiratory Health, created at the University of Barcelona with the support of the pharmaceutical companies AstraZeneca, Chiesi and GSK, will be presented. The new chair will be led by Àlvar Agustí, professor of Pulmonology at the Faculty of Medicine and Health Sciences.

 

IParticipants in this event are the vice-rector for Entrepreneurship, Transfer and Innovation, Albert Cirera; the dean of the Faculty of Medicine and Health Sciences, Antoni Trilla; the director of the chair, Àlvar Agustí, and the national directors of the three pharmaceutical companies that take part in the chair.

Respiratory diseases are very common among population. A shocking example is the current COVID-19 pandemic, a primarily respiratory disease. In addition, recent research studies led by UB researchers have shown that a person's circumstances at the beginning of his or her life — during gestation in the mother's womb, in childhood and adolescence — influence the development of the lungs, with a very significant impact on chronic respiratory diseases of the adult, such as chronic obstructive pulmonary disease (COPD) or asthma and probably COVID-19 as well. Therefore, taking care of respiratory health from the beginning of life is of great social and health importance to promote a healthy aging.

The main objective of this new UB Chair on Respiratory Health is to organize training activities regarding the relevance of respiratory health and the prevention and treatment of the most common respiratory diseases. The activities will be aimed at both health professionals (doctors, nurses, physiotherapists, etc.) and patients or the general audience. In this sense, there is a special interest in being able to evaluate the experience of patients in their transit through the health system (Barcelona Medical Association Janus group) and the added value of health actions (value based health care) in the field of respiratory diseases. In order to achieve these goals, the Chair will organize courses, meetings and debate forums (face-to-face and online) and will have an international advisory committee (think tank) to help in the design and setting of priorities.

Currently, Àlvar Agustí also directs the Global Initiative for Chronic Obstructive Pulmonary Disease. He is also a member of the August Pi i Sunyer Biomedical Research Institute (IDIBAPS) and the Respiratory Diseases Networking Biomedical Research Centre, and a member of the Royal Academy of Medicine of Catalonia.

You can access through this link (meeting IF: 894 5390 6057; access code: 854321).

 

Share this at:
| More |
  • Follow us:
  • Button to access University of Barcelona's Facebook profile
  • Button to access University of Barcelona's Twitter profile
  • Button to access University of Barcelona's Instagram profile
  • Button to access University of Barcelona's Linkedin profile
  • Button to access University of Barcelona's Youtube profile
  • Button to access University of Barcelona's Google+ profile
  • ??? peu.flickr.alt ???
Member of International recognition of excellence HR Excellence in Research logo del leru - League of European Research Universities logo del bkc - campus excel·lència logo del health universitat de barcelona campus

© Universitat de Barcelona